495 related articles for article (PubMed ID: 3012540)
21. Altered gene transcription after burn injury results in depressed T-lymphocyte activation.
Horgan AF; Mendez MV; O'Riordain DS; Holzheimer RG; Mannick JA; Rodrick ML
Ann Surg; 1994 Sep; 220(3):342-51; discussion 351-2. PubMed ID: 8092900
[TBL] [Abstract][Full Text] [Related]
22. Impaired expression of interleukin-2 receptor (IL2R) in the immunosuppressed burned patient: reversal by exogenous IL2.
Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Falk RE; Peters WJ
J Trauma; 1987 Feb; 27(2):180-7. PubMed ID: 3102753
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3 dependent cell line.
McCubrey JA; Steelman LS; McKearn JP
Oncogene Res; 1991; 6(1):1-12. PubMed ID: 1705318
[TBL] [Abstract][Full Text] [Related]
24. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines.
Dautry F; Weil D; Yu J; Dautry-Varsat A
J Biol Chem; 1988 Nov; 263(33):17615-20. PubMed ID: 3263373
[TBL] [Abstract][Full Text] [Related]
25. [The effect of heat shock on mRNA expression in human T lymphocytes].
Liu Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Dec; 12(6):416-20. PubMed ID: 2151259
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
Reed JC; Greene WC; Hoover RG; Nowell PC
J Immunol; 1985 Oct; 135(4):2478-82. PubMed ID: 3928749
[TBL] [Abstract][Full Text] [Related]
27. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte.
Reed JC; Sabath DE; Hoover RG; Prystowsky MB
Mol Cell Biol; 1985 Dec; 5(12):3361-8. PubMed ID: 3879814
[TBL] [Abstract][Full Text] [Related]
28. Antisense oligodeoxynucleotides for IL-2, c-myc and transferrin receptor synchronize mitogen-activated lymphocytes in the G1 phase.
Kato J; Kohgo Y; Kondo H; Sasaki K; Niitsu Y
Scand J Immunol; 1994 May; 39(5):499-504. PubMed ID: 8191225
[TBL] [Abstract][Full Text] [Related]
29. T lymphocytes infiltrating renal cell carcinoma have a reduced expression of transferrin receptor.
Kudoh S; Stanley J; Edinger MG; Tubbs RR; Klein E; Bukowski RM; Finke JH
Int J Cancer; 1994 Aug; 58(3):369-75. PubMed ID: 8050820
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
[TBL] [Abstract][Full Text] [Related]
31. Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.
Broome HE; Reed JC; Godillot EP; Hoover RG
Mol Cell Biol; 1987 Aug; 7(8):2988-93. PubMed ID: 3118189
[TBL] [Abstract][Full Text] [Related]
32. Effect of wheat germ agglutinin on T lymphocyte activation.
Kawakami K; Yamamoto Y; Onoue K
Microbiol Immunol; 1988; 32(4):413-22. PubMed ID: 3134597
[TBL] [Abstract][Full Text] [Related]
33. Sequential expression of genes involved in human T lymphocyte growth and differentiation.
Krönke M; Leonard WJ; Depper JM; Greene WC
J Exp Med; 1985 Jun; 161(6):1593-8. PubMed ID: 2989408
[TBL] [Abstract][Full Text] [Related]
34. Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell.
Hall SH; Berthelon MC; Avallet O; Saez JM
Endocrinology; 1991 Sep; 129(3):1243-9. PubMed ID: 1651842
[TBL] [Abstract][Full Text] [Related]
35. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
36. Trace metals, surface receptors and growth of human normal and leukemic lymphocytes.
Carpentieri U; Kalmaz G; Ezell E; Thorpe LW
Anticancer Res; 1988; 8(6):1393-7. PubMed ID: 3265316
[TBL] [Abstract][Full Text] [Related]
37. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.
Reed JC; Tsujimoto Y; Alpers JD; Croce CM; Nowell PC
Science; 1987 Jun; 236(4806):1295-9. PubMed ID: 3495884
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
40. Modulation of c-fos and c-myc mRNA levels in normal human lymphocytes by calcium ionophore A23187 and phorbol ester.
Grausz JD; Fradelizi D; Dautry F; Monier R; Lehn P
Eur J Immunol; 1986 Oct; 16(10):1217-21. PubMed ID: 3095123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
